Proceedings of the 2024 Third Annual ASTCT-NMDP ACCESS Initiative Workshop
Jeffery J. Auletta(Nationwide Children's Hospital), Stella M. Davies(Cincinnati Children's Hospital Medical Center), Eneida R. Nemecek(Oregon Health & Science University), Sarah Wall(The Ohio State University), Jennifer Holter‐Chakrabarty(University of Oklahoma Health Sciences Center), Pashna N. Munshi(Johns Hopkins Hospital), Nandita Khera(Mayo Clinic in Florida), Alexandra Gomez-Arteaga(Cornell University), Anurekha G. Hall(Seattle Children's Hospital), Amber Ruffin(National Marrow Donor Program), Jess Knutson(National Marrow Donor Program), Jackie Foster(National Marrow Donor Program), Delilah Robb(National Marrow Donor Program), Rayne H. Rouce(Baylor College of Medicine)
Cited by 10
Related Papers
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
|New England Journal of Medicine|2018|5.7k
Genetic mechanisms of target antigen loss in CAR19 therapy of acute lymphoblastic leukemia
|Nature Medicine|2018|577
Early cytomegalovirus reactivation remains associated with increased transplant-related mortality in the current era: a CIBMTR analysis
|Blood|2016|554
Increasing Incidence of Chronic Graft-versus-Host Disease in Allogeneic Transplantation: A Report from the Center for International Blood and Marrow Transplant Research
|Biology of Blood and Marrow Transplantation|2014|442
Three-Year Update of Tisagenlecleucel in Pediatric and Young Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia in the ELIANA Trial
|Journal of Clinical Oncology|2022|369